Edski, A good morning (evening perhaps) to you. Yes I tend to agree with you, I obviously think the data from the EAP - American Footballers program will be great but apart perhaps from a moderate up-day at the time, I think it will be a slow good burn thereafter as institutional investors discover us and do their own research. In theory we should get a nice gradual lift from it over the ensuing weeks after the announcement...we also should see perhaps a small to medium increase in volume over that time frame adding to the more gradual SP lift? The same could be applied to a (much) lesser extent for inclusion to the ASX 300 club.
Af far as the TGA program goes...hmm I'm in two minds here, there is a possibility with such good data to date that we have a chance of being accepted towards the back half of this year. However, depending on how things go, they (Par? TGA? A combo of the two) might wait for more empirical data ie the dosing phase study as part of Phase three, in which case this may preclude us out of this year and lend itself for us getting provisional approval by the TGA more towards Q1/Q2 next year? I suspect the later of the two has a higher chance of occurring?
Definitely agree with you, the "log" on the fire of the TGA initial first revenue could be a large lift for us independent of any other news. There is nothing like the prospect and subsequent delivery of real revenue albeit modest initially, to prove to the world that what we have is real. I can clearly see a lot of pushing and shoving to get the box office to buy PAR tickets aggressively when this occurs.
All speculation of course...just gotta wait it out really.
- Forums
- ASX - By Stock
- ASX 300 listing
Edski, A good morning (evening perhaps) to you. Yes I tend to...
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 118621 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 0.240 |
4 | 27745 | 0.235 |
1 | 25000 | 0.230 |
5 | 41756 | 0.225 |
7 | 59930 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 74601 | 4 |
0.255 | 50000 | 1 |
0.260 | 21333 | 2 |
0.265 | 69367 | 4 |
0.270 | 53000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online